Degradation of Amyotrophic Lateral Sclerosis-linked Mutant Cu,Zn-Superoxide Dismutase Proteins by Macroautophagy and the Proteasome

Tomohiro Kabuta, Yasuyuki Suzuki, Keiji Wada

Journal of Biological Chemistry · 2006 · 221 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

Mutations in the Cu,Zn-superoxide dismutase (SOD1) gene cause ∼20% of familial cases of amyotrophic lateral sclerosis (fALS). Accumulating evidence indicates that a gain of toxic function of mutant SOD1 proteins is the cause of the disease. It has also been shown that the ubiquitin-proteasome pathway plays a role in the clearance and toxicity of mutant SOD1. In this study, we investigated the degradation pathways of wild-type and mutant SOD1 in neuronal and nonneuronal cells. We provide here the first evidence that wild-type and mutant SOD1 are degraded by macroautophagy as well as by the proteasome. Based on experiments with inhibitors of these degradation pathways, the contribution of macroautophagy to mutant SOD1 clearance is comparable with that of the proteasome pathway. Using assays that measure cell viability and cell death, we observed that under conditions where expression of mutant SOD1 alone does not induce toxicity, macroautophagy inhibition induced mutant SOD1-mediated cell death, indicating that macroautophagy reduces the toxicity of mutant SOD1 proteins. We therefore propose that both macroautophagy and the proteasome are important for the reduction of mutant SOD1-mediated neurotoxicity in fALS. Inhibition of macroautophagy also increased SOD1 levels in detergent-soluble and -insoluble fractions, suggesting that both detergent-soluble and -insoluble SOD1 are degraded by macroautophagy. These findings may provide further insights into the mechanisms of pathogenesis of fALS. Mutations in the Cu,Zn-superoxide dismutase (SOD1) gene cause ∼20% of familial cases of amyotrophic lateral sclerosis (fALS). Accumulating evidence indicates that a gain of toxic function of mutant SOD1 proteins is the cause of the disease. It has also been shown that the ubiquitin-proteasome pathway plays a role in the clearance and toxicity of mutant SOD1. In this study, we investigated the degradation pathways of wild-type and mutant SOD1 in neuronal and nonneuronal cells. We provide here the first evidence that wild-type and mutant SOD1 are degraded by macroautophagy as well as by the proteasome. Based on experiments with inhibitors of these degradation pathways, the contribution of macroautophagy to mutant SOD1 clearance is comparable with that of the proteasome pathway. Using assays that measure cell viability and cell death, we observed that under conditions where expression of mutant SOD1 alone does not induce toxicity, macroautophagy inhibition induced mutant SOD1-mediated cell death, indicating that macroautophagy reduces the toxicity of mutant SOD1 proteins. We therefore propose that both macroautophagy and the proteasome are important for the reduction of mutant SOD1-mediated neurotoxicity in fALS. Inhibition of macroautophagy also increased SOD1 levels in detergent-soluble and -insoluble fractions, suggesting that both detergent-soluble and -insoluble SOD1 are degraded by macroautophagy. These findings may provide further insights into the mechanisms of pathogenesis of fALS. Amyotrophic lateral sclerosis (ALS) 2The abbreviations used are: ALS, amyotrophic lateral sclerosis; fALS, familial ALS; SOD1, Cu,Zn-superoxide dismutase(s); 3-MA, 3-methyladenine; siRNA, short interfering RNA; EGFP, enhanced green fluorescent protein; HA, hemagglutinin; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium. is a neurodegenerative disease caused by selective loss of motor neurons (1Bruijn L.I. Miller T.M. Cleveland D.W. Annu. Rev. Neurosci. 2004; 27: 723-749Crossref PubMed Scopus (1196) Google Scholar, 2Cleveland D.W. Rothstein J.D. Nat. Rev. Neurosci. 2001; 2: 806-819Crossref PubMed Scopus (1181) Google Scholar). Although most cases of ALS are sporadic, ∼10% of ALS cases run in families. Dominant missense mutations in the gene that encodes the Cu,Zn-superoxide dismutase (SOD1) are responsible for 20% of familial ALS (fALS) cases (3Rosen D.R. Siddique T. Patterson D. Figlewicz D.A. Sapp P. Hentati A. Donaldson D. Goto J. O'Regan J.P. Deng H.X. Rahmani Z. Krizus A. McKenna-Yasek D. Cayabyab A. Gaston S.M. Berger R. Tanzi R.E. Halperin J.J. Herzfeldt B. Van den Bergh R. Hung W.Y. Bird T. Deng G. Mulder D.W. Smyth C. Laing N.G. Soriano E. Pericak-Vance M.A. Haines J. Rouleau G.A. Gusella J.S. Horvitz H.R. Brown Jr., R.H. Nature. 1993; 362: 59-62Crossref PubMed Scopus (5530) Google Scholar). Mice overexpressing mutant SOD1 develop an ALS-like phenotype comparable with human ALS, whereas mice lacking SOD1 do not (4Gurney M.E. Pu H. Chiu A.Y. Dal Canto M.C. Polchow C.Y. Alexander D.D. Caliendo J. Hentati A. Kwon Y.W. Deng H.X. Chen W. Zhai P. Sufit R.L. Siddique T. Science. 1994; 264: 1772-1775Crossref PubMed Scopus (3475) Google Scholar, 5Reaume A.G. Elliott J.L. Hoffman E.K. Kowall N.W. Ferrante R.J. Siwek D.F. Wilcox H.M. Flood D.G. Beal M.F. Brown Jr., R.H. Scott R.W. Snider W.D. Nat. Genet. 1996; 13: 43-47Crossref PubMed Scopus (1048) Google Scholar). These findings have led to the conclusion that SOD1 mutants cause motor neuron degeneration by a toxic gain of function. Thus, studies of the degradation process of mutant SOD1 proteins could provide important insights into understanding the mechanisms that underlie the pathology of fALS, and possibly sporadic ALS, and into developing novel therapies for fALS by removing toxic species of mutant SOD1. Cytoplasmic proteins are mainly degraded by two pathways, the ubiquitin-26 S proteasome pathway (6Goldberg A.L. Nature. 2003; 426: 895-899Crossref PubMed Scopus (1672) Google Scholar) and autophagy (7Cuervo A.M. Trends Cell Biol. 2004; 14: 70-77Abstract Full Text Full Text PDF PubMed Scopus (715) Google Scholar). Previous studies have shown that mutant SOD1 proteins are turned over more rapidly than wild-type SOD1, and a proteasome inhibitor increases the level of mutant SOD1 proteins (8Hoffman E.K. Wilcox H.M. Scott R.W. Siman R. J. Neurol. Sci. 1996; 139: 15-20Abstract Full Text PDF PubMed Scopus (108) Google Scholar, 9Johnston J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google Scholar). Dorfin and NEDL1, two distinct ubiquitin ligases, ubiquitinate mutant but not wild-type SOD1 (10Niwa J. Ishigaki S. Hishikawa N. Yamamoto M. Doyu M. Murata S. Tanaka K. Taniguchi N. Sobue G. J. Biol. Chem. 2002; 277: 36793-36798Abstract Full Text Full Text PDF PubMed Scopus (175) Google Scholar, 11Miyazaki K. Fujita T. Ozaki T. Kato C. Kurose Y. Sakamoto M. Kato S. Goto T. Itoyama Y. Aoki M. Nakagawara A. J. Biol. Chem. 2004; 279: 11327-11335Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar). These observations suggest that mutant SOD1 is degraded by the ubiquitin-26 S proteasome pathway and that the increased turnover of mutant SOD1 is mediated in part by this pathway. On the other hand, the 20 S proteasome, a component of the 26 S proteasome, can degrade proteins without a requirement for ubiquitination (12Shringarpure R. Grune T. Mehlhase J. Davies K.J. J. Biol. Chem. 2003; 278: 311-318Abstract Full Text Full Text PDF PubMed Scopus (361) Google Scholar, 13Asher G. Tsvetkov P. Kahana C. Shaul Y. Genes Dev. 2005; 19: 316-321Crossref PubMed Scopus (312) Google Scholar). A recent study has found that metal-free forms of wild-type and mutant SOD1 are degraded by the 20 S proteasome in vitro (14Di Noto L. Whitson L.J. Cao X. Hart P.J. Levine R.L. J. Biol. Chem. 2005; 280: 39907-39913Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar). Autophagy is an intracellular process that results in the degradation of cytoplasmic components inside lysosomes. At least three forms of autophagy have been described in mammalian cells: macroautophagy, microautophagy, and chaperone-mediated autophagy (7Cuervo A.M. Trends Cell Biol. 2004; 14: 70-77Abstract Full Text Full Text PDF PubMed Scopus (715) Google Scholar). Macroautophagy is the major and the most well studied form of autophagy; this process begins with a sequestration step, in which cytosolic components are engulfed by a membrane sac called the isolation membrane. This membrane results in a double membrane structure called the autophagosome, which fuses with the lysosome. The inner membrane of the autophagosome and its protein and organelle contents are degraded by lysosomal hydrolases. Recent reports have demonstrated that macroautophagy plays an important role in preventing neurodegeneration in mice (15Komatsu M. Waguri S. Chiba T. Murata S. Iwata J. Tanida I. Ueno T. Koike M. Uchiyama Y. Kominami E. Tanaka K. Nature. 2006; 441: 880-884Crossref PubMed Scopus (2850) Google Scholar, 16Hara T. Nakamura K. Matsui M. Yamamoto A. Nakahara Y. Suzuki-Migishima R. Yokoyama M. Mishima K. Saito I. Okano H. Mizushima N. Nature. 2006; 441: 885-889Crossref PubMed Scopus (3130) Google Scholar). Although macroautophagy can be induced by starvation, this pathway may take place constitutively in mammals (17Komatsu M. Waguri S. Ueno T. Iwata J. Murata S. Tanida I. Ezaki J. Mizushima N. Ohsumi Y. Uchiyama Y. Kominami E. Tanaka K. Chiba T. J. Cell Biol. 2005; 169: 425-434Crossref PubMed Scopus (1929) Google Scholar). In cultured cells, inhibition of macroautophagy does not alter enhanced green fluorescent protein (EGFP) levels (18Ravikumar B. Duden R. Rubinsztein D.C. Hum. Mol. Genet. 2002; 11: 1107-1117Crossref PubMed Scopus (938) Google Scholar) or glyceraldehyde-3-phosphate dehydrogenase protein levels, 3T. Kabuta, Y. Suzuki, and K. Wada, unpublished data. suggesting that not all cytosolic proteins are degraded by macroautophagy. To date, however, there have been no reports of macroautophagy in mutant SOD1 clearance. In this study, we investigated the pathway by which human wild-type SOD1 and the A4V, G85R, and G93A SOD1 mutants are degraded in neuronal and nonneuronal cells. We show that wild-type and mutant SOD1 proteins are degraded by both the proteasomal pathway and macroautophagy. The experiments with inhibitors of these degradation pathways suggested that mutant SOD1 are degraded more rapidly than wild-type SOD1 in part by macroautophagy and that the contribution of macroautophagy to mutant SOD1 clearance is approximately equal to that of the proteasome pathway. Macroautophagy decreases mutant SOD1 protein levels in both nonionic detergent-soluble and -insoluble fractions. In addition, we provide data indicating that macroautophagy has a role in mutant SOD1-mediated cell death. Plasmid Constructs—The expression plasmids pcDNA3-hSOD1 containing wild-type, A4V, G85R, and G93A mutant SOD1 by and M. J. K. R. J. 2002; PubMed Scopus Google Scholar). To a human wild-type SOD1 with the the of SOD1, SOD1 by wild-type SOD1 as the The with and and into an The used and A G93A SOD1 to the To a protein of green fluorescent protein and by as the The with and and into a The used and the of the plasmids by Cell and cell the human cell and the cell in with expression of in and the experiments with cells, the to with and 20 of in in conditions not and there no in the the of with or in or to with expression plasmids containing wild-type, A4V, G85R, or G93A mutant SOD1. with or or or 20 or as a In to the to the of protein and in in in Cell of nonionic and -insoluble fractions, and on for in containing and inhibitors for and the and as the detergent-soluble fractions. the with with and and The used as the of cell containing both detergent-soluble and -insoluble fractions, in and with the protein or the protein as described T. T. S. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). The used as with with or with or and with a The by and and by siRNA, and siRNA, and siRNA, and used as a with of and of of Cell and Cell in with cultured in with or without for Cell by a dehydrogenase the membrane to the The of to this of cell we used the and the with the cell and cell viability to the with a to of two the by of more than two of the of used as a and SOD1 by the SOD1 is degraded by the proteasome we the of proteasome inhibitors on SOD1 protein clearance. as or and are used proteasome also and and A A.L. Trends Cell Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, H. C. S. S. L. T. K. P. J. Cell Biol. 2000; PubMed Scopus (42) Google Scholar). these inhibitors are not and may with lysosomal we used as a selective proteasome inhibitor L. R. M. N. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, C. Rev. Chem. 2002; 2: PubMed Scopus Google Scholar). We observed protein clearance of human SOD1 in with mutant or wild-type SOD1 in the of the inhibitor and with reports J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google Scholar, 11Miyazaki K. Fujita T. Ozaki T. Kato C. Kurose Y. Sakamoto M. Kato S. Goto T. Itoyama Y. Aoki M. Nakagawara A. J. Biol. Chem. 2004; 279: 11327-11335Abstract Full Text Full Text PDF PubMed Scopus (140) Google wild-type SOD1 a of more than with mutant SOD1 The degradation of wild-type and mutant SOD1 by and in that mutant SOD1 is degraded by the proteasome is in with reports (8Hoffman E.K. Wilcox H.M. Scott R.W. Siman R. J. Neurol. Sci. 1996; 139: 15-20Abstract Full Text PDF PubMed Scopus (108) Google Scholar, 9Johnston J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google Scholar). To human wild-type SOD1 is also degraded by the proteasome, SOD1 clearance the human cell The proteasome inhibitor the of human SOD1 proteins and These results that wild-type SOD1 is degraded by the proteasome, also with a (14Di Noto L. Whitson L.J. Cao X. Hart P.J. Levine R.L. J. Biol. Chem. 2005; 280: 39907-39913Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar). and SOD1 by date, there have been no reports of macroautophagy in human SOD1 clearance. We therefore investigated wild-type or mutant SOD1 degraded by macroautophagy 3-MA, an inhibitor of macroautophagy (18Ravikumar B. Duden R. Rubinsztein D.C. Hum. Mol. Genet. 2002; 11: 1107-1117Crossref PubMed Scopus (938) Google Scholar, Y. A. J. N. M. Hum. Mol. Genet. 2003; PubMed Scopus Google Scholar, A.M. L. R. D. Science. 2004; PubMed Scopus Google and an inhibitor of lysosomal A.M. L. R. D. Science. 2004; PubMed Scopus Google Scholar). We that the of in green fluorescent a of Y. Mizushima N. Ueno T. Yamamoto A. T. T. Kominami E. Ohsumi Y. T. J. 2000; 19: PubMed Scopus Google Scholar) we also that the clearance of an for macroautophagy J.L. B. J. Rubinsztein D.C. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google by or of with the of G93A mutant SOD1 proteins In the of the degradation of wild-type and mutant SOD1 by with and more than in indicating that wild-type and mutant SOD1 are degraded by macroautophagy in these and that the of SOD1 proteins by is not to increased protein These with suggest that mutant SOD1 are degraded more rapidly than wild-type SOD1 by macroautophagy is that of wild-type SOD1 and of mutant SOD1 degraded by macroautophagy the The clearance of mutant G93A SOD1 also by with shown in and the protein level of SOD1 increased by or The shown in further the role of the in SOD1 To the role of macroautophagy on SOD1 degradation in neuronal or we also used cells. In cells, increased both wild-type and mutant SOD1 protein levels in the or of not To human SOD1 is degraded by macroautophagy, the clearance of SOD1 in cells. shown in and the degradation of SOD1 proteins by further of the clearance of SOD1 by macroautophagy, we used to induce macroautophagy J.J. P.J. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, G.A. 2004; Full Text Full Text PDF PubMed Scopus Google and gene with to macroautophagy. with G93A SOD1 levels A and In cells, SOD1 protein levels also by is a component of a that is for macroautophagy S. M. Brown K. B. H. Levine B. Nature. PubMed Scopus Google Scholar). of the gene by the of preventing macroautophagy S. T. Mizushima N. T. S. Y. Nat. Cell Biol. 2004; PubMed Scopus Google Scholar). protein is also for macroautophagy (17Komatsu M. Waguri S. Ueno T. Iwata J. Murata S. Tanida I. Ezaki J. Mizushima N. Ohsumi Y. Uchiyama Y. Kominami E. Tanaka K. Chiba T. J. Cell Biol. 2005; 169: 425-434Crossref PubMed Scopus (1929) Google Scholar). We that or expression by or siRNA, A and We also that level increased by or We observed degradation of wild-type and mutant SOD1 in with A and or and with with in The results shown in that wild-type and mutant SOD1 are also degraded by macroautophagy in neuronal cells. In the nonneuronal cells, or the of wild-type SOD1 and G93A SOD1 or mutant G93A SOD1 of the with also increased wild-type and mutant SOD1 levels and These results that wild-type and mutant SOD1 are degraded by both macroautophagy and the proteasome in cells. The results shown in and that not SOD1 without a but also SOD1 is degraded by of macroautophagy the of SOD1 proteins. A and with SOD1 A4V, G85R, or and or cell and by or used as a of SOD1 by and the levels are as level of SOD1 in with over with are as the and with SOD1 A4V, G85R, or and or cell and by or of SOD1 by and the levels are as level of SOD1 in with over with are as the with G93A SOD1 and or with for the and cell by or and wild-type SOD1 are degraded by both macroautophagy and the proteasome in cells. with human wild-type SOD1 or G93A SOD1. with or without 20 for cell by or and used as with G93A mutant SOD1 with or without in the of for cell by of SOD1 by and the levels are as level of SOD1 in with over are as the with wild-type or mutant or G93A SOD1. with or without for cell by The of the and Macroautophagy to SOD1 the of proteasomal degradation and macroautophagy to the clearance of mutant SOD1. shown in the degradation of mutant SOD1. also the degradation of mutant SOD1 and we mutant G93A SOD1 levels in with that of cells. The SOD1 protein level in comparable with that of increased of mutant SOD1 in with both inhibitors with that of or and These data further the that mutant SOD1 proteins are degraded by both macroautophagy and the proteasome and in these cells, the contribution of macroautophagy to mutant SOD1 clearance is approximately equal to that of the proteasome pathway. Macroautophagy the of studies have shown that mutant are more to cell induced by proteasome inhibition K. G. J. 2003; PubMed Scopus (42) Google Scholar). We the degradation of mutant SOD1 could also induce cell in three of cell we used the and and for of cell death, we used the dehydrogenase In cells, there no in cell viability or cell cells, wild-type cells, and mutant with 3-MA, mutant increased cell and cell viability with or wild-type with cell of cells, cell of increased in mutant but not in with wild-type SOD1 these we that macroautophagy reduces mutant SOD1-mediated toxicity in this cell Inhibition of Macroautophagy to of both and SOD1 or have been found in motor neurons in fALS S. M. K. A. Cleveland D.W. H. N. Kato M. I. E. 2000; PubMed Scopus Google of fALS L.I. N.G. Rothstein J.D. D.R. Cleveland D.W. Full Text Full Text PDF PubMed Scopus Google and the with mutant SOD1 J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google Scholar, G. A. S. J. Cell Biol. 2005; PubMed Scopus Google is not these SOD1 proteins and are toxic of results on the and cell G. A. S. J. Cell Biol. 2005; PubMed Scopus Google Scholar, J.P. C. Miller R. G. J. 2002; PubMed Scopus Google Scholar). We investigated the of macroautophagy inhibition on the clearance of nonionic detergent-soluble and -insoluble SOD1. The nonionic detergent-soluble and -insoluble to In with a J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google mutant SOD1 proteins increased nonionic with wild-type SOD1 The increased level of wild-type SOD1 with mutant in the detergent-soluble is to the turnover of mutant SOD1. with increased SOD1 levels in the detergent-soluble and -insoluble suggesting that both detergent-soluble and -insoluble SOD1 are degraded by macroautophagy. with a J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google we found and of mutant SOD1 in the These and of mutant SOD1 increased by suggesting that of mutant SOD1 are also by macroautophagy. The results and that the of toxic mutant SOD1 proteins by macroautophagy inhibition to cell death. Using inhibitors of macroautophagy and proteasomal we have shown that both wild-type and mutant SOD1 proteins are degraded by both Accumulating evidence has shown that mutant SOD1 is degraded by the ubiquitin-proteasome pathway (8Hoffman E.K. Wilcox H.M. Scott R.W. Siman R. J. Neurol. Sci. 1996; 139: 15-20Abstract Full Text PDF PubMed Scopus (108) Google Scholar, 9Johnston J.A. Dalton M.J. Gurney M.E. Kopito R.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12571-12576Crossref PubMed Scopus (512) Google Scholar, M. J. K. R. J. 2002; PubMed Scopus Google Scholar). most of these studies have used or a both of which are not data on the of the selective proteasome inhibitor also that mutant SOD1 is degraded by the proteasome. wild-type SOD1 is not by the ubiquitin (10Niwa J. Ishigaki S. Hishikawa N. Yamamoto M. Doyu M. Murata S. Tanaka K. Taniguchi N. Sobue G. J. Biol. Chem. 2002; 277: 36793-36798Abstract Full Text Full Text PDF PubMed Scopus (175) Google Scholar, 11Miyazaki K. Fujita T. Ozaki T. Kato C. Kurose Y. Sakamoto M. Kato S. Goto T. Itoyama Y. Aoki M. Nakagawara A. J. Biol. Chem. 2004; 279: 11327-11335Abstract Full Text Full Text PDF PubMed Scopus (140) Google has been that wild-type SOD1 is not a of the proteasome. a recent has suggested that wild-type SOD1 can be degraded by the 20 S proteasome without ubiquitination (14Di Noto L. Whitson L.J. Cao X. Hart P.J. Levine R.L. J. Biol. Chem. 2005; 280: 39907-39913Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar). we show here that increases both and wild-type SOD1 data with the reports the that wild-type SOD1 is degraded by the 20 S proteasome in mammalian cells. In this study, we demonstrated for the first that macroautophagy is pathway for degradation of wild-type and mutant SOD1. findings are with a that wild-type SOD1 is in and in not SOD1 degraded by macroautophagy in C. J.D. J. Cell Biol. 1993; PubMed Scopus Google Scholar). We propose that the contribution of macroautophagy to mutant SOD1 degradation is comparable with that of the proteasome pathway in the cell we Recent studies have demonstrated that mice with expression of mutant SOD1 do not an ALS-like phenotype A. J. J. K. Rouleau G.A. J. Neurosci. 2001; PubMed Google Scholar, C. P. J. Neurosci. 2002; PubMed Google Scholar) and that neurodegeneration is motor neurons mutant SOD1 are by nonneuronal wild-type A.M. S. M. W. Siwek D. Ferrante R.J. Brown Jr., R.H. J.P. Cleveland D.W. Science. 2003; PubMed Scopus Google Scholar). In addition, M. A. T. N. R. J.P. Nat. Neurosci. 2006; PubMed Scopus Google Scholar) have shown that of mutant SOD1 the mutant and that mutant SOD1 can be toxic to cells. These studies suggest that the expression of mutant SOD1 in nonneuronal may be in mutant SOD1-mediated In nonneuronal cells, mutant SOD1 is also degraded by both the proteasome and macroautophagy Thus, not the proteasome but also macroautophagy may an important role in clearance of mutant SOD1 in fALS in nonneuronal as well as in neuronal cells. It has been well that mutant SOD1-mediated toxicity is caused by a gain of toxic function than the loss of SOD1 (1Bruijn L.I. Miller T.M. Cleveland D.W. Annu. Rev. Neurosci. 2004; 27: 723-749Crossref PubMed Scopus (1196) Google Scholar, 2Cleveland D.W. Rothstein J.D. Nat. Rev. Neurosci. 2001; 2: 806-819Crossref PubMed Scopus (1181) Google Scholar). The of mutant SOD1 in motor neurons in fALS and of fALS S. M. K. A. Cleveland D.W. H. N. Kato M. I. E. 2000; PubMed Scopus Google Scholar, L.I. N.G. Rothstein J.D. D.R. Cleveland D.W. Full Text Full Text PDF PubMed Scopus Google Scholar) has suggested that has a role in results have been on the and cell death. A recent study has shown that the of mutant and G93A SOD1 proteins to form with neuronal cell cell G. A. S. J. Cell Biol. 2005; PubMed Scopus Google Scholar). has that of and SOD1 mutants does not with cell J.P. C. Miller R. G. J. 2002; PubMed Scopus Google Scholar). These also in other neurodegenerative M. S. S. Nature. 2004; PubMed Scopus Google Scholar, S. D. M.E. Full Text Full Text PDF PubMed Scopus Google Scholar, G. P. R. C. N. N. H. K. M. Mol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, Jr., M. M.F. H. M. H. S. J. T.M. Science. 2001; PubMed Scopus Google Scholar). data suggest that macroautophagy toxic species of mutant SOD1 and that the of mutant SOD1 proteins to cell death. the toxic SOD1 species are or be study, a of mutant SOD1 detergent-soluble SOD1 and and by macroautophagy inhibition data show that macroautophagy reduces mutant SOD1-mediated toxicity and that of macroautophagy decreases mutant SOD1 protein (10Niwa J. Ishigaki S. Hishikawa N. Yamamoto M. Doyu M. Murata S. Tanaka K. Taniguchi N. Sobue G. J. Biol. Chem. 2002; 277: 36793-36798Abstract Full Text Full Text PDF PubMed Scopus (175) Google Scholar) have shown that the ubiquitin Dorfin mutant SOD1 and the neurotoxicity of mutant SOD1. these data that macroautophagy of the ubiquitin-proteasome or a of the two have for fALS. In results that mutant SOD1 is degraded by least two pathways, macroautophagy and the proteasome and that the clearance of mutant SOD1 by macroautophagy reduces its cell These findings may provide into the mechanisms of the pathogenesis of fALS. We and for the of pcDNA3-hSOD1 and mutant A4V, G85R, and and for the in

References

39